Compare $BCAB vs $KAPA | Chartloom

Compare

$BCAB vs $KAPA

Bioatla Inc · Kairos Pharma Ltd

BCAB

Bioatla Inc

KAPA

Kairos Pharma Ltd

Compare $BCAB vs $KAPA

Comparing Bioatla Inc and Kairos Pharma Ltd

BCABBioatla Inc

KAPAKairos Pharma Ltd

BCABBioatla Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-22.7%

YTD performance

-94.4%

52W performance

-96.7%

FCF yield

-943.1%

KAPAKairos Pharma Ltd

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.1%

52W performance

-91.2%

FCF yield

-22.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAB

KAPA

Detailed metrics comparison

BCAB

Bioatla Inc

KAPA

Kairos Pharma Ltd

Market Cap

BCAB$2M

KAPA$17M

Enterprise Value

BCAB$946K

KAPA$15M

Price

BCAB$1.50

KAPA$0.81

P/E Ratio

BCABN/A

KAPAN/A

P/S Ratio

BCAB0.29x

KAPA0.00x

EV/Sales

BCAB0.11x

KAPA0.00x

EV/EBITDA

BCAB0.00x

KAPA0.00x

P/B Ratio

BCAB4.57x

KAPA1.26x

P/FCF Ratio

BCABN/A

KAPAN/A

EV/FCF

BCAB-0.04x

KAPA-3.71x

PEG Ratio

BCABN/A

KAPAN/A

Forward P/E (NTM)

BCABN/A

KAPAN/A

Forward P/S (NTM)

BCABN/A

KAPAN/A

Revenue (TTM)

BCAB$9M

KAPA$0

Revenue Growth (YoY)

BCAB-22.7%

KAPAN/A

Forward Rev Growth

BCAB0.0%

KAPA0.0%

Gross Margin (TTM)

BCAB0.0%

KAPA0.0%

Operating Margin (TTM)

BCAB0.0%

KAPA0.0%

EBITDA Margin (TTM)

BCAB-369.8%

KAPA0.0%

Net Margin (TTM)

BCAB-370.0%

KAPA0.0%

FCF Margin (TTM)

BCAB-276.3%

KAPAN/A

Net Income (TTM)

BCAB$-31M

KAPA$-6M

FCF (TTM)

BCAB$-23M

KAPA$-4M

EPS (TTM)

BCAB-$18.93

KAPA-$0.27

ROE (TTM)

BCAB-35792.0%

KAPA-9877.0%

ROA (TTM)

BCAB-26317.0%

KAPA-9361.0%

ROIC (TTM)

BCAB-35792.0%

KAPA-9877.0%

Cash

BCAB$2M

KAPA$3M

Debt

BCAB$0

KAPA$0

Net Cash/Debt

BCAB$2M

KAPA$3M

Current Ratio (TTM)

BCAB0.20x

KAPA11.98x

Quick Ratio (TTM)

BCAB0.17x

KAPA11.46x

Debt/Equity (TTM)

BCAB0.00x

KAPA0.00x

Debt/Assets (TTM)

BCAB0.0%

KAPA0.0%

Interest Coverage (TTM)

BCABN/A

KAPAN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

KAPA0.00x

Beta

BCAB0.63

KAPA3.30

52W Performance

BCAB-96.7%

KAPA-91.2%

YTD Performance

BCAB-94.4%

KAPA-84.1%

% from 52W High

BCAB-97.9%

KAPA-91.6%

% from 52W Low

BCAB40.2%

KAPA3.5%

Asset Turnover (TTM)

BCAB0.73x

KAPA0.00x

FCF Yield (TTM)

BCAB-943.1%

KAPA-22.9%

Earnings Yield (TTM)

BCAB-1263.2%

KAPA-33.5%

Dividend Yield (TTM)

BCABN/A

KAPAN/A

Rule of 40

BCAB-299.0

KAPA0.0

EV/GP/RG

BCABN/A

KAPAN/A

Ticker research

View BCAB research View KAPA research

Metric	BCAB Bioatla Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$2M	$17M
Enterprise Value	$946K	$15M
Price	$1.50	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	0.00x
EV/Sales	0.11x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.57x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$0
Revenue Growth (YoY)	-22.7%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	0.0%
Net Margin (TTM)	-370.0%	0.0%
FCF Margin (TTM)	-276.3%	N/A
Net Income (TTM)	$-31M	$-6M
FCF (TTM)	$-23M	$-4M
EPS (TTM)	-$18.93	-$0.27
ROE (TTM)	-35792.0%	-9877.0%
ROA (TTM)	-26317.0%	-9361.0%
ROIC (TTM)	-35792.0%	-9877.0%
Financial Health
Cash	$2M	$3M
Debt	$0	$0
Net Cash/Debt	$2M	$3M
Current Ratio (TTM)	0.20x	11.98x
Quick Ratio (TTM)	0.17x	11.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	3.30
52W Performance	-96.7%	-91.2%
YTD Performance	-94.4%	-84.1%
% from 52W High	-97.9%	-91.6%
% from 52W Low	40.2%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-943.1%	-22.9%
Earnings Yield (TTM)	-1263.2%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAB research	View KAPA research

Valuation

P/S Ratio

KAPA

0.00x

BCAB

0.29x

EV/FCF

KAPA

-3.71x

BCAB

-0.04x

Growth & revenue

Revenue Growth TTM

BCAB

-22.7%

Forward Revenue Growth

BCAB

0.0%

KAPA

0.0%

Profitability & performance

Gross Margin

BCAB

0.0%

KAPA

0.0%

ROE

KAPA

-9877.0%

BCAB

-35792.0%

FCF Yield %

KAPA

-22.9%

BCAB

-943.1%

52-Week Performance

KAPA

-91.2%

BCAB

-96.7%

Detailed metrics comparison

BCAB

Bioatla Inc

KAPA

Kairos Pharma Ltd

Market Cap

BCAB$2M

KAPA$17M

Enterprise Value

BCAB$946K

KAPA$15M

Price

BCAB$1.50

KAPA$0.81

P/E Ratio

BCABN/A

KAPAN/A

P/S Ratio

BCAB0.29x

KAPA0.00x

EV/Sales

BCAB0.11x

KAPA0.00x

EV/EBITDA

BCAB0.00x

KAPA0.00x

P/B Ratio

BCAB4.57x

KAPA1.26x

P/FCF Ratio

BCABN/A

KAPAN/A

EV/FCF

BCAB-0.04x

KAPA-3.71x

PEG Ratio

BCABN/A

KAPAN/A

Forward P/E (NTM)

BCABN/A

KAPAN/A

Forward P/S (NTM)

BCABN/A

KAPAN/A

Revenue (TTM)

BCAB$9M

KAPA$0

Revenue Growth (YoY)

BCAB-22.7%

KAPAN/A

Forward Rev Growth

BCAB0.0%

KAPA0.0%

Gross Margin (TTM)

BCAB0.0%

KAPA0.0%

Operating Margin (TTM)

BCAB0.0%

KAPA0.0%

EBITDA Margin (TTM)

BCAB-369.8%

KAPA0.0%

Net Margin (TTM)

BCAB-370.0%

KAPA0.0%

FCF Margin (TTM)

BCAB-276.3%

KAPAN/A

Net Income (TTM)

BCAB$-31M

KAPA$-6M

FCF (TTM)

BCAB$-23M

KAPA$-4M

EPS (TTM)

BCAB-$18.93

KAPA-$0.27

ROE (TTM)

BCAB-35792.0%

KAPA-9877.0%

ROA (TTM)

BCAB-26317.0%

KAPA-9361.0%

ROIC (TTM)

BCAB-35792.0%

KAPA-9877.0%

Cash

BCAB$2M

KAPA$3M

Debt

BCAB$0

KAPA$0

Net Cash/Debt

BCAB$2M

KAPA$3M

Current Ratio (TTM)

BCAB0.20x

KAPA11.98x

Quick Ratio (TTM)

BCAB0.17x

KAPA11.46x

Debt/Equity (TTM)

BCAB0.00x

KAPA0.00x

Debt/Assets (TTM)

BCAB0.0%

KAPA0.0%

Interest Coverage (TTM)

BCABN/A

KAPAN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

KAPA0.00x

Beta

BCAB0.63

KAPA3.30

52W Performance

BCAB-96.7%

KAPA-91.2%

YTD Performance

BCAB-94.4%

KAPA-84.1%

% from 52W High

BCAB-97.9%

KAPA-91.6%

% from 52W Low

BCAB40.2%

KAPA3.5%

Asset Turnover (TTM)

BCAB0.73x

KAPA0.00x

FCF Yield (TTM)

BCAB-943.1%

KAPA-22.9%

Earnings Yield (TTM)

BCAB-1263.2%

KAPA-33.5%

Dividend Yield (TTM)

BCABN/A

KAPAN/A

Rule of 40

BCAB-299.0

KAPA0.0

EV/GP/RG

BCABN/A

KAPAN/A

Ticker research

View BCAB research View KAPA research

Metric	BCAB Bioatla Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$2M	$17M
Enterprise Value	$946K	$15M
Price	$1.50	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	0.00x
EV/Sales	0.11x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.57x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$0
Revenue Growth (YoY)	-22.7%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	0.0%
Net Margin (TTM)	-370.0%	0.0%
FCF Margin (TTM)	-276.3%	N/A
Net Income (TTM)	$-31M	$-6M
FCF (TTM)	$-23M	$-4M
EPS (TTM)	-$18.93	-$0.27
ROE (TTM)	-35792.0%	-9877.0%
ROA (TTM)	-26317.0%	-9361.0%
ROIC (TTM)	-35792.0%	-9877.0%
Financial Health
Cash	$2M	$3M
Debt	$0	$0
Net Cash/Debt	$2M	$3M
Current Ratio (TTM)	0.20x	11.98x
Quick Ratio (TTM)	0.17x	11.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	3.30
52W Performance	-96.7%	-91.2%
YTD Performance	-94.4%	-84.1%
% from 52W High	-97.9%	-91.6%
% from 52W Low	40.2%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-943.1%	-22.9%
Earnings Yield (TTM)	-1263.2%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAB research	View KAPA research